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Summary: A new solid-phase antigen immunoassay was developed for the detection of anti-zona pellucida-
antibodies. The assay was validated in a double blind study with clinically defmed sera. The new assay is
easy to perform and large numbers of sera can be processed in one day. The antigen can be prepared in
advance and stored until use. This represents an advantage over other methods, such äs immunofluorescence
and RIA, which require fresh antigen preparation for each set of assays. With this new test ca. 7% of females
and ca. 20% of males with unexplained infertility have shown elevated antibody concentrations compared
with fertile controls. The estimated intra-assay and inter-assay CV were 8.5% and less than 10% respectively.
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 n aration (14) was used which was ob_
Furthermore it was reported that the sera of mferti e solubilization of porcine zona pellucida
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Materials and Methods
I so la t ion of zonae pellucidae
The method of Gwalkin et al. (17) was used for the large scale
isolation of approximately 50000 porcine zonae. Briefly the
procedure was s follows: the whole ovaries were minced,
digested vvith collagenase (Sigma Chem. Co. Deisenhofen,
FRG) and filtered through nylon screens of various pore sizes.
Following the last filtration through a 75 μτη screen, the residue
was suspended in 0.05 moi/1 phosphate buffer, pH 7.3 in 0.15
mol/1 NaCl and checked for purity under the microscope.
body concentrations in the sera of patients were calculated
(19 a) according to the equation
average counts/min χ BC
1290 χ SAng IgG =
where
BC = binding capacity of 125I-protein-A in ng/ng
1290 (couBts/min)/nCi = c nstant ,
 f
SA = specific activity of the 125I-protein-A in nCi/ng
All assays were carried out in triplicate.
Solubilization of zonae pellucidae
The solubilization procedure was basically that described by
Dietl et al. (16). The 50000 zonae were suspended in l ml of
0.3 mol/1 lithium 3',5'-diiodosalicylate in 0.05 mol/1 Tris/HCl
buffer, pH 7.5. The Suspension was stirred for 15 min at room
temperature, and an equal volume of distilled water was added.
The diluted mixture was then incubated for an additional 10
min and centrifuged at 45 000 g for 90 min at 4 °C. The Sediment
was discarded and the supernatant mixed with a 50 g/l phenol/
water solution at a volume ratio of l : l, to eliminate any
possible contamination by protein. The Suspension was then
stirred for anotheir 50 min at 4 °C, centrifuged at 4000 g for 60
min (4 °C) and the aqueous phase separated. The latter was
then dialysed for 48 h against several changes of bi-distilled
water at 4 °C. The dialysate was lyophilized and the glycopro-
teins were precipitated in absolute ethanol. The precipitate was
then collected by centrifugation at 4000 g for 60 min at 4 °C
and dissolved l ml of 0.05 mol/1 buffer in 0.15 mol/1 NaCl, pH
7.3.
Preparation of the antigen-coated solid-phase
The procedure was basically the same s described previously
for the detection of antisperm antibodies (18). The solubilized
antigens were incubated with nylon beads (Paesel, 3 mm dia-
meter) at 90 mg protein per 60 beads per ml, with gentle shaking
for 120 min at room temperature. This was followed by an
overnight incubation at 4 °C. The beads were then washed in
ice-cold 0.05 mol/1 phosphate buffer pH 7.8, dried and stored
at 4 °C until use. The same antigen mixture was used for several
batches of new coatings, since only a fraction of the antigen is
bound to the nylon surface at this protein concentration.
Test sera
The sera were sent to the laboratory frozen, on dry ice, from the
WHO Reference Bank for Reproductive Immunology, Aarhus,
Denmark. All sera were thawed once just prior to the assays.
The double blind study was coordinated by Dr. Hjort under
the trial number of 77180 and included sera of clinically defmed
categories s follows (number of sera in parenthesis):
Females: fertiie (20), post-partum (15), postanenopausal (7),
primary amenorrhoe (2), virgin (12), pregnant (37), recurrent
abortion (13), unexplained infertile (84).
Males: fertiie (16), congenital absence of vas (3), aspermatoge-
nesis (5), vasectomy (15), unexplained infertile (83).
Among the coded sera there were also 30 matched pairs with
randomly distributed sample numbers. These sera were used
for the estimation of reproducibility.
Quality control
In order to maintain an adequate quality control, a positive
control serum, rabbit anti-porcine-zona pellucida^anti-serurn,
(6) with known titre, was aliquoted, frozen at —70 °C and
thawed only once to be included with each set of assays. This
procedure ensured that both the test sera and the positive
control serum were frozen and thawed only once. The intra?
assay and inter-assay CV were estimated.
Sperm-agglutination
tests
and sperm-immobilization
The sperm-agglutination and sperm-immobilization test where
carried out according to the method of Friberg (21) and
Husted & Hjort (22).
Preparation of the radiolabelled tracer
Protein-Α, which preferentially binds to the Fc portions of
antibodies (mainly to IgG's and IgM), was used s a tracer
(18). The labelling with 125I was carried out s described pre-
viously (19). The specific activity was calculated at 259
Solid-phase antigen immunoassay
The patient sera were diluted l : 100 with the above buffer and
200 μΐ were pipetted into separate RIA tubes, each containing
an antigen-coated bead. The beads were incubated for 60 min
at 37 °C and washed three times with 0.05 mol/1 phosphate
buffer in 0.15 mol/1 NaCl, containing 1% (by vol.) Tweeh-20.
Following the last wash, 200 μΐ of the radio-labelled tracer
(1.72 kBq) was pipetted into each tube and these were incubated
and washed again s described above. After the last wash the
beads were transferred to new tubes and counted in a gamma
counter for l min each. The bound anti-zona pellucida-anti-
Results
Females
The normal r nge of anti-zona pellucida-antibody
concentrations, based on the results of the fertiie··
groups, was estimated to be 0.1 — 1.47 μg/l IgG.
The sera of six out of 84 female patients (ca. 7%)
with unexplained infertility showed an elevated auto-
antibody concentration compared with fertiie con-
trols. A Box & Whisker plot of the results indicates
a higher median for the infertile group and elevated
anti-zona pellucida-antibody concentrations in six
cases compared with the fertiie group (fig. 1). In
addition, one out of 13 patients #ith recurrent abor-
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Males Tab. 1. a = Distribution of elevated anti-zona pellucida-anti-
body concentration in the various clinical cat-
egories of female patients.
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& Whisker distributions plots of the anti-zona
pellucida-antibody levels in the clinically defined sera
from the WHO.
The 25% and 75% interquartile distances are drawn s
boxes.
Medi n: (— ),
arithmetic mean: (>·<),
n: number of patents.
The extreme values are plotted individually.
α recurrent abortion
A vasectomy
tion also showed increased antibody concentration.
The values of all other clinical categories were within
the normal r nge of fertiles (tab. l a). In all cases the
conventional agglutination and immobilization tests
failed to detect the presence of antisperm-antibodies.
The clinical history revealed that the highest level of
auto-antibody concentration was present in the serum
of a patient with a secondary infertility of 2 years
duration. In general five out of the six positive sera
were secondary infertility cases of between 2 to 10
years duration. No correlatipn between length of
infertility and a to-antibody concentration was ob-
served. The pne patient with primary infertility had
failed to conceive for six years.
Males
The normal r nge of astibody conpentration in the
fertile male group was estimated at 0.1 — l .1 μg/l IgG.
Using the Box-Whisker pl t (flg. 1), 12 cases in the
unexplained infertile groups show a higher median
and increased antibody concentrations compared
with the fertile controls. Three out of the 15 patients
were in the vasectomized category. Other patients*
with either aspermatogenesis of congenital absence
of vas, showed antibody levels similar to those of
the fertiles (tab. l b). The sperm agglutination and
immobilization test were negative in all cases.
Clinical category
Unexplained infertile
Recurrent abortion
Post-menopausal
Post-partum
Prim r y amenorrhoe
Pregnant
Virgin
Females
Number
of sera
84
13
7
15
2
37
12
Number of cases of
elevated antibody
concentration in the
different categories
6
0
0
0
0
0
Tab. 1. b = Distribution of elevated anti-zona pellucida-anti-
body concentration in the various clinical cat-
egories of male patients.
Clinical category Males
Number Number of cases of
of sera elevated antibody
concentration in the
different categories
Unexplained infertile 83 12
Vasectomy 15 3
Aspermatogenesis 5 0
Congenital absence of vas 3 0
The day to day Variation of the assay with the positive
control serum was less than 10% C. V. and the aver-
age intra-assay C.V. was calculated at 8.5%. The
positive control serum, rabbit anti-porcine-zona pel-
lucida-anti-serum, showed an average binding of 3.95
± 0.29 μg/l IgG (n = 10).
Discussion
The results of this study with clinically defined sera
suggest that anti-zona pellucida-antibodies could be
the c use of unexplained infertility in both males and
females in some cases. This is in agreement with the
results of other investigators (5, 8, 10).
In earlier studies Shivers & Dunbar (23) have shown
that 32% of infertile woman had elevated antibody-
concentrations against porcine zona pellucida. They
concluded that some cases of unexplained infertility
could result from auto-antibodies. Similar auto-anti-
bodies in sera of infertile patients have been described
by Mori et al. (5). In the male patients (infertile and
vasectomized) this could possibly be explained by
the common pntogenic origin of the germ cells s
primordial germ cells in both females and males.
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These authors used different detection methods,
which would be difficult to adapt for routine diag-
nosis.
Defining an exact "cut off level based on parametric
statistics is difficult since biological data are not nor-
mally distributed. The common practice of using the
ränge of normal values in a negative control group
(in this case, fertiles) could be adopted (in analogy
to assays for tumour markers), provided that each
laboratory establishes its own normal values, with
clinically defmed sera.
So far, however, there are no reliable assays for the
detection of such antibodies. Most of these assays
are difficult to perform on a routine basis in the
sterility clinics. Our results indicate that the new
solid-phase antigen assay could be used routinely
äs an additional aid for the detection of anti-zona
pellucida-antibodies äs an immunological cause of
infertility.
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